An obvious potential caveat of total CCR4 blockade as an asthma treatment is the potential for the impairment of regulatory T cell recruitment, since T-regulatory cells (Tregs) have been shown to express CCR4 and to migrate in vitro in response to both CCL17 and CCL22 (Iellem et al., 2001). This evidence concerns the gene CCL17 and asthma.